Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 2/20 | 0.62 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.56 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.56 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.56 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.56 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.56 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.56 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.56 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.47 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29721478 | 1.00 | ROCK1 (0.62) | ROCK1GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL18012073 | 0.90 | ROCK1 (0.64) | ROCK1GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL29721693 | 0.81 | ROCK1 (0.61) | ROCK1ALDH1A1MAPTLMNATP53 | |
| SCHEMBL3239758 | 0.81 | ROCK1 (0.61) | ROCK1ALDH1A1MAPTLMNATP53 | |
| SCHEMBL9379977 | 0.81 | ROCK1 (0.61) | ROCK1ALDH1A1MAPTLMNATP53 | |
| SCHEMBL17335801 | 0.81 | ROCK1 (0.57) | ROCK1GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL28518109 | 0.81 | GRIN2D (0.49) | ROCK1GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL29721709 | 0.81 | ROCK1 (0.49) | ROCK1GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL29721714 | 0.81 | ROCK1 (0.63) | ROCK1GRIN1GRIN2BGRIN2DGRIN3B | |
| SCHEMBL29721770 | 0.81 | ROCK1 (0.63) | ROCK1GRIN1GRIN2BGRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108947896-B | Synthetic method of alpha-aryl-alpha- (5-pyridyl) acetate derivative | 华南理工大学 | 2021-09-21 | — | — | CN | disclosed |
| US-20060241149-A1 | Chemical compounds | ADAMS JERRY L | 2006-10-26 | — | — | US | disclosed |
| EP-1581514-A2 | CHEMICAL COMPOUNDS | SmithKline Beecham Corporation (US) | 2005-10-05 | — | — | EP | disclosed |
| WO-2004043379-A2 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-05-27 | — | — | WO | disclosed |
| EP-1349535-A2 | INDOLE/INDOLINE BASED HYBRID DYES AND INDOLE/INDOLINE BASED HYBRID DYE INTERMEDIATE PRODUCTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-10-08 | — | — | EP | disclosed |
| WO-2002055609-A2 | INDOLE/INDOLINE BASED HYBRID DYES AND INDOLE/INDOLINE BASED HYBRID DYE INTERMEDIATE PRODUCTS | HENKEL KGAA (DE) | 2002-07-18 | — | — | WO | disclosed |
| WO-2000006575-A2 | AZABICYCLIC COMPOUNDS | SMITHKLINE BEECHAM PLC (GB) | 2000-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241149-A1 | Chemical compounds | CHKB, MAP3K20, MAP3K6 | ROCK1 739/4885GRIN1 3082/4885GRIN2B 3238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.